Evercore ISI Group analyst Jonathan Chappell upgrades Cheniere Energy Partners (AMEX:CQP) from In-Line to Outperform and raises the price target from $54 to $55.
FDA Gives Nod To Eli Lilly’s First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie
The FDA approved Eli Lilly And Co's
